Masergy Releases 2019 SD-WAN Market Trends Report
16.7.2019 14:00:00 EEST | Business Wire | Press release
Masergy, a leading provider of managed SD-WAN, cloud communications and managed security solutions, today announced results from its new 2019 SD-WAN Market Trends Survey, which found that security drives selection, skills gaps remain a primary obstacle to adoption, and adoption continues to rise.
The survey, conducted in partnership with IDG Research, analyzed responses from IT decision makers in global enterprises across a variety of industries. This survey was also conducted in 2017 as a benchmark in order to measure SD-WAN trends over time. Optimizing the network to support cutting-edge technology stands out as the most prominent objective that was covered in the survey. Most survey participants find that security is the biggest WAN challenge, even outweighing cost concerns. Managing numerous users, devices, and locations is also an increasing pain point.
Key findings from the 2019 survey include:
● Optimizing the network to support cutting-edge technologies remains the top WAN objective (61%) among survey participants.
● Security (50%) is the top WAN challenge and the leading factor (81%) guiding companies in the SD-WAN selection process.
● The skills gap (46%) remains a top barrier to SD-WAN adoption, whereas concerns regarding interoperability with existing WANs are less prevalent than they were two years ago.
● SD-WAN adoption rates increased from 35% to 54% over the past two years, with 90% of respondents’ actively researching, piloting, actively using or upgrading SD-WAN.
● Network management simplification (46%) continues to be the top expected IT benefit of SD-WAN adoption, and the top three expected business benefits of SD-WAN are increased efficiency, improved security, and cost savings.
“Masergy pioneered software-defined networking two decades ago, and this survey validates the growing maturity of SD-WAN solutions. IT leaders are tasked with transforming their business through cloud-based applications and emerging technologies, but these pivots introduce a new level of complexity that can be daunting for network and security teams,” said Masergy CEO James Parker. “Masergy is uniquely positioned to deliver on the digital ambitions of today’s global enterprises with our software-defined network, integrated security, and fully-managed SD-WAN services.”
Download Masergy’s 2019 SD-WAN Market Trends Report for a detailed view into the research results.
About Masergy
Masergy enables global enterprises to innovate, disrupt and dominate their industries with transformative solutions in managed SD-WAN, cloud communications and managed security. Built on the world’s most innovative Software Defined Platform, our agile technologies, customizable solutions, and unmatched customer experience are why leading organizations rely on Masergy to stay ahead of the competition. Be what’s next with Masergy. Learn more and follow us on our blog Transforming Enterprise IT, Twitter@Masergy, LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190716005291/en/
Contact information
Company Contact:
Sunita Mani
214.442.5740
sunita.mani@masergy.com
Media Contact:
Calin Gunn
802.779.7040
calin@bluetext.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration10.8.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, and Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced a multi-part collaboration including: a clinical collaboration to evaluate drug combinations incorporating select clinical-stage oncology assets from BeOne with any of Revolution Medicines’ four clinical RAS(ON) inhibitors, and a separate regional rights agreement granting BeOne exclusive development and commercialization rights to these Revolution Medicines assets in select Asian markets. Clinical collaboration will explore potential targeted combination approaches for patients with RAS-addicted cancers Potential drug combinations for development as part of the clinical collaboration will include certain BeOne assets and Revolution Medicines’ four clinical RAS(ON) inhibitors: daraxonrasib, a RAS(ON) multi-selective inhibitor; zo
OpenGate Capital to Acquire Maersk Training, the Global Safety Training and Gas-Safety Services Business of Maersk10.8.2026 09:00:00 EEST | Press release
OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire Maersk Training and its subsidiary Maersk H2S Safety Services. The company, a provider of global safety training and gas safety services, is being carved out from A.P. Møller - Mærsk A/S (MAERSK A:CPH), a listed integrated logistics company. Headquartered in Svendborg, Denmark, Maersk Training is a leading global provider of essential safety services that operates through two complementary business segments. The first segment, Maersk H2S Safety Services, is a specialist provider of outsourced hydrogen sulphide and Health, Safety and Environment safety services, which include onsite supervision, monitoring and safety equipment maintenance for customers in high-risk operating environments. The second segment, Training Business, is a global provider of safety training, competency development and simulation, delivered through instructor led, digital and virtual
Ant International’s Bettr Partners with Muslim Pro to Introduce Umrah Financing Service in Malaysia10.8.2026 06:49:00 EEST | Press release
Bettr, a leading provider of inclusive and embedded finance and fintech solutions under Ant International, today announced its partnership with Muslim Pro, a popular Islamic lifestyle app serving over 190 million downloads worldwide, to launch an Umrah financing solution in Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260809780047/en/ Ant International's Bettr and Muslim Pro launch an Umrah financing solution in Malaysia to help families better manage their cash flow and spread pilgrimage costs responsibly. The solution is designed for eligible Muslims who have the means to undertake the pilgrimage but prefer to spread its cost over time. This flexibility enables individuals and families to manage their cash flow responsibly, maintain regular savings and preserve sufficient liquidity for emergencies and other financial obligations. The launch marks a significant milestone in Bettr’s Islamic finance initiative and
ICC Arbitral Tribunal Issues Quantum Award for AOP Health in BESREMi® Proceedings7.8.2026 20:48:00 EEST | Press release
An ICC Arbitral Tribunal has awarded AOP Orphan Pharmaceuticals GmbH (“AOP Health”) a total of about EUR 112 Mio in a quantum award issued in the ongoing arbitration proceedings with PharmaEssentia Corp. (“PharmaEssentia”) concerning BESREMi® (ropeginterferon alfa-2b). The award quantifies AOP Health’s damage claims for PharmaEssentia’s intentional breaches at ca. EUR 82 Mio. It also awards AOP Health ca. EUR 31 Mio plus interest as reimbursement for AOP Health overpayments made to PharmaEssentia as a result of excessive pricing in the years 2019-2022. The Tribunal thereby confirmed that PharmaEssentia has been overcharging AOP Health by up to 900% over these years. The Tribunal affirmed AOP Health's valid set-off of the profit-sharing payments amount owed to PharmaEssentia of approximately EUR 17 Mio against AOP Health's substantially exceeding damages claims. This means that AOP Health shall not make any payment to PharmaEssentia. Interest on AOP Health’s claims will continue to accr
Coulson Aviation Canada Acquires 10 Former RCAF Hercules, Doubling C-130H Fleet7.8.2026 20:16:00 EEST | Press release
Coulson Aviation Canada, the Canadian division of Coulson Aviation, has acquired 10 former Royal Canadian Air Force CC-130H Hercules aircraft from the Government of Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260807019094/en/ Britton Coulson, left, and Wayne Coulson stand in front of one of 10 former Royal Canadian Air Force CC-130H Hercules aircraft recently acquired by Coulson Aviation from the Government of Canada. At right is a Coulson C-130H outfitted for aerial firefighting with the company’s proprietary RADS-XXL retardant delivery system, capable of carrying up to 4,000 U.S. gallons, or more than 15,000 litres, of water or fire retardant. The acquisition doubles Coulson’s global C-130H fleet to 20 aircraft, expanding its capacity to build the world’s largest C-130 airtanker fleet. The acquisition doubles Coulson’s global C-130H fleet from 10 aircraft to 20 and gives its Canadian division the scale to build
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom